British Journal of Radiology (BRIT J RADIOL)

Publisher: British Institute of Radiology, British Institute of Radiology

Journal description

The British Journal of Radiology is the official peer reviewed journal of the British Institute of Radiology covering all clinical and technical aspects of diagnostic imaging, radiotherapy and radiobiology.

Current impact factor: 2.03

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 2.026
2013 Impact Factor 1.533
2012 Impact Factor 1.217
2011 Impact Factor 1.314
2010 Impact Factor 2.062
2009 Impact Factor 2.105
2008 Impact Factor 2.366
2007 Impact Factor 1.773
2006 Impact Factor 1.279
2005 Impact Factor 1.394
2004 Impact Factor 1.232
2003 Impact Factor 1.089
2002 Impact Factor 0.925
2001 Impact Factor 0.959
2000 Impact Factor 0.951
1999 Impact Factor 1.067
1998 Impact Factor 0.867
1997 Impact Factor 0.811
1996 Impact Factor 0.794
1995 Impact Factor 0.675
1994 Impact Factor 0.766
1993 Impact Factor 0.694
1992 Impact Factor 0.671

Impact factor over time

Impact factor

Additional details

5-year impact 1.98
Cited half-life 9.20
Immediacy index 0.30
Eigenfactor 0.01
Article influence 0.67
Website British Journal of Radiology website
Other titles British journal of radiology, BJR
ISSN 0007-1285
OCLC 1537310
Material type Periodical
Document type Journal / Magazine / Newspaper

Publisher details

British Institute of Radiology

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Restrictions
    • 12 months embargo
  • Conditions
    • On funder's repositories, institutional repository or subject-based repositories
    • Publisher's version/PDF can be used on non-commercial open access repositories
    • Published source must be acknowledged
    • Must link to publisher version
    • Authors retain copyright
    • Author copyright and source must be acknowledged with full citation and set statement (see policy)
    • Non-commercial use
    • Publisher last contacted on 20/06/2013
  • Classification
    ​ yellow

Publications in this journal

  • British Journal of Radiology 08/2015; DOI:10.1259/bjr.20150362
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper describes the external audit measurements conducted in 2 UK centres implementing Total Skin Electron Beam Therapy (TSEBT) and the results obtained. Measurements of output, energy, beam flatness and symmetry at standard distance (95cmSSD or 100cmSSD) were performed using a parallel plate chamber in solid water. Similarly, output and energy measurements were also performed at the treatment plane for single and dual fields. Clinical simulations were carried out using thermoluminescent dosemeters (TLD) and Gafchromic film on an anthropomorphic phantom. Extended distance measurements confirmed local values for the beam dosimetry at centres A and B were within 2% for outputs and 1mm agreement of the expected R50,D value. Clinical simulation using TLD showed an agreement of -1.6% and -6.7% compared to the expected mean trunk dose for each centre respectively and a variation within 10% (±1SD) across the trunk. The film results confirmed that the delivery of the treatment technique at each audited centre complies with EORTC recommendations. This audit methodology has proven to be a successful way to confirm the agreement of dosimetric parameters for TSEBT treatments at both audited centres and could serve as the basis for an audit template to be used by other audit groups. Advances In Knowledge: TSEBT audits are not established in the UK due to a limited number of centres carrying out the treatment technique. This paper describes the audits performed at two UK centres prior to their clinical implementation.
    British Journal of Radiology 03/2015; 88(1049):20140723. DOI:10.1259/bjr.20140723
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents an overview of the recent developments and requirements in radiotherapy dosimetry, with a particular emphasis on the development of optical fibre dosimeters for radiotherapy applications, focusing particularly on in-vivo applications. Optical fibres offer considerable advantages over conventional techniques for radiotherapy dosimetry, due to their small size, immunity to electromagnetic interferences and their suitability for remote monitoring and multiplexing. The small dimensions of optical fibre based dosimeters, together with being lightweight and flexible, mean that they are minimally invasive and thus particularly suited to in-vivo dosimetry. This means that the sensor can be placed directly inside a patient, e.g. for brachytherapy treatments, the optical fibres could be placed in the tumour itself, or into nearby critical tissues requiring monitoring, via the same applicators or needles used for the treatment delivery thereby providing real-time dosimetric information. The paper outlines the principal sensor design systems along with some of the main strengths and weaknesses associated with the development of these techniques. The successful demonstration of these sensors in a range of different clinical environments is also presented.
    British Journal of Radiology 03/2015; 88(1050):20140702. DOI:10.1259/bjr.20140702
  • [Show abstract] [Hide abstract]
    ABSTRACT: In 2011, the ICRP recommended a substantial reduction in the equivalent dose limit for the lens of the eye, in line with a reduced threshold of absorbed dose for radiation-induced cataracts. This is of particular relevance in Interventional Radiology (IR) where it is well established that staff doses can be significant, however there is a lack of data on IR eye doses in terms of Hp(3). Hp(3) is the personal dose equivalent at a depth of 3mm in soft tissue and is used for measuring lens dose. We aimed to obtain a reliable estimate of eye dose to IR operators. Lens doses were measured for four interventional radiologists over a 3-month period using dosimeters specifically designed to measure Hp(3). Based on their typical workloads, two of the four interventional radiologists would exceed the new ICRP dose limit with annual estimated doses of 31mSv and 45mSv to their left eye. These results are for an "unprotected" eye and for IR staff who routinely wear lead glasses, the dose beneath the glasses is likely to be significantly lower. Staff eye dose normalised to patient Kerma-Area Product (KAP) and eye dose per procedure has been included in the analysis. Eye doses to IR operators have been established using a dedicated Hp(3) dosimeter. Estimated annual doses have the potential to exceed the new ICRP limit. Advances in knowledge: We have estimated lens dose to interventional radiologists in terms of Hp(3) for the first time in an Irish hospital setting.
    British Journal of Radiology 03/2015; 88(1049):20140627. DOI:10.1259/bjr.20140627
  • [Show abstract] [Hide abstract]
    ABSTRACT: Visuospatial ability is fundamental to the cognitive understanding of the three-dimensional environment, and is widely recognised as an important skill in the performance of challenging visuospatial tasks. Its contribution to attainment and performance in a variety of professional disciplines is recognised, but there is relatively little known in relation to its relevance in radiological practice. On the basis of a review of the existing cognitive psychological literature and on the basis of the author's own observations, and on the assumption that spatial ability is of increasing and fundamental importance to high-level performance as a radiologist, it is proposed that consideration should be given to the testing of visuospatial ability as part of the selection process for prospective applicants to radiology training programmes.
    British Journal of Radiology 03/2015; 88(1049):20140511. DOI:10.1259/bjr.20140511
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the last decade, electronic brachytherapy (EB) has emerged as an attractive modality for the treatment of skin lesions and intraoperative partial breast irradiation, as well as finding wider applications in intracavitary and interstitial sites. These miniature x-ray sources, which operate at low kilovoltage energies (<100kV), have reduced shielding requirements and inherent portability, so can be used outside the traditional realms of the radiotherapy department. However, steep dose gradients and increased sensitivity to inhomogeneities challenge accurate dosimetry. Secondly, ease of use does not mitigate the need for close involvement by Medical Physics Experts and consultant oncologists. Finally, further studies are needed to relate the more heterogeneous dose distributions to clinical outcomes. With these provisos, the practical convenience of EB strongly suggests that it will become an established option for selected patients, not only in radiotherapy departments but also in a range of operating theatres and clinics around the world.
    British Journal of Radiology 03/2015; 88(1049):20150002. DOI:10.1259/bjr.20150002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: This study investigated the effectiveness of stereotactic body radiotherapy with helical tomotherapy (T-SBRT) for treating medically inoperable primary and second-primary (SPLN) early stage non-small cell lung neoplasm and evaluated whether the movement of organising pneumonia (OP) within the irradiation field (IF) can be detected via analysis of radiological changes. Methods: Patients (n = 16) treated for 1 year (2011-2012) at our hospital by T-SBRT at a total dose of 60 Gy in five fractions were examined retrospectively. Outcome and toxicity were recorded, and were separately described for SPLN. Computed tomography scans were reviewed by a single radiologist. Results: Of 16 the patients, five (31.3%) had primary lung malignancies, 10 (62.5%) had SPLN, and one case (6.2%) had isolated mediastinal metastasis of lung neoplasm. Pathological evidence was obtained for 72.2% of all lesions. The median radiological follow-up was 11.0 months (10.5 for SPLN). For all cases, the 6- and 12-month survival rates were 100% and 77.7% (100% and 71.4%, respectively, for SPLN), and the 6- and 12-month loco-regional control rates were 100% in all cases. Two (12.5%) of 16 patients developed grade 3 late transient radiation pneumonitis following steroid therapy and one (6.2%) presented asymptomatic infiltrates comparable to OP opacities. Conclusions: T-SBRT seems to be safe and effective. Advances in knowledge: Mild OP is likely associated with radiation-induced anomalies in the IF, identification of migrating opacities can help discern relapse of radiation-induced opacities.
    British Journal of Radiology 03/2015; 88(1049):20140687. DOI:10.1259/bjr.20140687
  • [Show abstract] [Hide abstract]
    ABSTRACT: Central nervous system (CNS) stimulation is becoming increasingly prevalent. Deep brain stimulation (DBS) has been proven to be an invaluable treatment for movement disorders and is also useful in many other neurological conditions refractory to medical treatment such as chronic pain and epilepsy. Neuroimaging plays an important role in operative planning, target localisation and in post-operative follow up. The use of imaging in determining the underlying mechanisms of DBS is increasing, and the dependence on imaging is likely to expand as deep brain targeting becomes more refined. This article will address the expanding role of radiology and highlight issues, including MRI safety concerns, that radiologists may encounter when confronted with a patient with CNS stimulation equipment in situ.
    British Journal of Radiology 02/2015; 88(1048):20140507. DOI:10.1259/bjr.20140507
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Intravenous pulse methylprednisolone therapy (IPMT) is an important treatment option for postinfectious obliterative bronchiolitis (OB), although it must be used carefully and only in selected patients because of its drawbacks. This study evaluated whether computed tomography (CT) and clinical features of children with postinfectious OB can predict their responsiveness to IPMT. Methods: We searched the medical records for patients (< 18 years) who were diagnosed with postinfectious OB between January 2000 and December 2011. Seventeen children who received IPMT were included in this study. All underwent chest CT before and after IPMT. The radiologic features seen on pretreatment CT were recorded. The air-trapping area percentages on pre- and post-treatment CT images were determined. The nine patients who exhibited decreased air-trapping on post-treatment CT scans relative to pretreatment scans, were classed as responders. The patient ages and time from the initial pneumonia to IPMT were recorded. Results: All responders, but only four non-responders, had thickened bronchial walls before treatment (p = 0.029). The two groups did not differ significantly in terms of bronchiolitis, bronchiectasis or the air-trapping extent, although the responders had a significantly shorter median interval between the initial pneumonia and IPMT (4 vs. 50 months, p = 0.005) and were significantly younger (median, 2 vs. 7.5 years, p = 0.048). Conclusions: Immediate IPMT may improve the degree of air-trapping in children with postinfectious OB if they show a thickened bronchial wall on CT. Advances in knowledge: Children with postinfectious OB may respond favorably to IPMT when pretreatment CT indicates bronchial-wall thickening.
    British Journal of Radiology 02/2015; 88(1049):20140478. DOI:10.1259/bjr.20140478
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To analyze imaging features of subtypes of Castleman Disease (CD), emphasizing differentiating features from lymphoma. Methods: IRB-approved, HIPAA compliant, retrospective study examined 30 patients with CD. 30 patients (20 women, mean age: 46 years, range 22-87) with histopathologically confirmed CD and pre-treatment imaging formed the analytic cohort. Imaging at presentation in all patients (30 CT, 5 PET/CT, 4 MR, 3 US) and subsequent imaging in three cases that developed lymphoma was reviewed by two radiologists in consensus. Results: Subtypes: hyaline-vascular(n=18); multicentric not otherwise specified (NOS)(n=6); HHV-8 associated( n=2); mixed unicentric(n=2); pure plasma-cell variant(n=1); unicentric NOS(n=1). Distribution: unicentric(n=17); multicentric(n=13). Nodal sites: unicentric: 13thoracic, 3abdominal and 1 cervical; multicentric: 9abdominal, 8thoracic, 6cervical, 5inguinal, 4axillary and 4supraclavicular. On CT, differentiating features from lymphoma were calcification(n=8; 26.7%) and heterogeneous enhancement(n=5; 19.2%). No association between CD subtype, degree or enhancement pattern, or calcification was noted. On PET/CT(n=5), nodes were typically FDG-avid(n=4). On ultrasound(n=3), nodes were hypoechoic, homogeneous with posterior acoustic enhancement. On MR(n=4), nodes were hypointense(n=2) to isointense(n=2) on T1-weighted images and isointense(n=1) to hyperintense(n=3) on T2-weighted images. All(n=4) demonstrated homogeneous enhancement. Three cases developed non-Hodgkin's lymphoma, 2 of the 3 had larger spleens, and these cases had effusions/ascites. Conclusions: CD can be unicentric or multicentric, and involve nodes above and below the diaphragm. Patients with CD can develop lymphoma. Advances in knowledge: Assessing individual risk of developing lymphoma in patients with CD is difficult, though the findings of splenomegaly, pleural effusion and ascites may be suggestive.
    British Journal of Radiology 02/2015; 88(1049):20140670. DOI:10.1259/bjr.20140670
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: To evaluate the role of an ultra-low-dose dual-source computed tomography coronary angiography (CTCA) scan with high pitch for delimiting the range of the subsequent standard CTCA scan. Methods: Thirty patients with an indication for CTCA were prospectively examined using a two-scan dual-source CTCA protocol (2 x 64 x 0.6 mm; pitch 3.4; rotation time of 280 msec; 100 kV): Scan 1 acquired with one fifth of the tube current suggested by the automatic exposure control software (CareDose 4D, using 100 kV and 370 mAs as a reference) with the scan length from the tracheal bifurcation to the diaphragmatic border. Scan 2 was acquired with standard tube current extending with reduced scan length based on Scan 1. Nine central coronary artery segments were analyzed qualitatively on both scans. Results: Scan 2 (105.1±10.1mm) was significantly shorter than Scan 1 (127.0±8.7mm). Image quality scores were significantly better for Scan 2. However, in 5 of 6 patients (83%) with stenotic coronary artery disease, a stenosis was already detected in Scan 1 and in 13 of 24 patients (54%) with non-stenotic coronary arteries, a stenosis was already excluded by Scan 1. Using Scan 2 as reference, the positive and negative predictive value of Scan 1 was 83% (5 of 6 patients) and 100% (13 of 13 patients), respectively. Conclusions: An ultra-low-dose CTCA planning scan enables a reliable scan length reduction of the following standard CTCA scan and allows for correct diagnosis in a substantial proportion of patients. Advances in knowledge: Further dose reductions are possible due to a change in the individual patient's imaging strategy as a prior ultra-low-dose CTCA scan may already rule out the presence of a stenosis or may lead to a direct transferal to an invasive catheter procedure.
    British Journal of Radiology 02/2015; 88(1049):20140602. DOI:10.1259/bjr.20140602
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: We report our experience in providing palliative radiation (RT) to patients with head and neck cancers (HNC). Our hypofractionated regimen, "0-7-21", treats patients with 24 Gy in 3 fractions. Methods: Patients, disease and response data were retrieved for candidates of "0-7-21" from 2005-2012. Primary endpoints included symptom and tumour size responses to RT based on RECIST guidelines. Secondary endpoints included progression-free survival within the irradiated field (PFS), overall survival (OS) and symptomatic progression-free survival (SPFS), calculated using Kaplan-Meier method and adverse events. Cox proportional hazards regression and logistic regression were used to investigate for prognostic factors. Results: A total of 110 patients were included. Among the patients, 40% and 31% had complete response for symptoms and tumour size respectively, 42% and 50% had partial response for symptoms and tumour size respectively, and 15% had stability of symptom and tumour size. Median 6-months OS was 51% and PFS within the irradiated field was 39%. Planning target volume was predictive of OS (p<0.001), PFS (p<0.001) and SPFS (p<0005) while higher TNM stage was associated with poorer tumour response (p=0.02). Conclusion: "0-7-21" is an effective and well-tolerated palliative RT regimen for patients with HNC. There was excellent symptom and local control with acceptable toxicity profile in these patients. Advances in knowledge: This is the first study to describe the outcomes of 0-7-21 in treating advanced head and neck cancers. The positive results suggest that 0-7-21 provides excellent palliation with minimal toxicity, with significantly less on-treatment time than current published palliative RT regimen.
    British Journal of Radiology 02/2015; 88(1049):20140646. DOI:10.1259/bjr.20140646